BNP Paribas Financial Markets’s 10x Genomics TXG Stock Holding History

BNP Paribas Financial Markets’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.91M	Buy	101,852 +38,980	+62%	+$1.02M	﹤0.01%	2288
2026 Q1	$1.33M	Buy	62,872 +10,757	+21%	+$215K	﹤0.01%	2938
2025 Q4	$850K	Sell	52,115 -25,741	-33%	-$389K	﹤0.01%	3222
2025 Q3	$910K	Sell	77,856 -77,443	-50%	-$1.01M	﹤0.01%	3194
2025 Q2	$1.8M	Sell	155,299 -498,499	-76%	-$4.54M	﹤0.01%	2545
2025 Q1	$5.71M	Buy	653,798 +21,267	+3%	+$268K	﹤0.01%	1727
2024 Q4	$9.08M	Buy	+632,531	New	+$9.98M	0.01%	1414

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets's TXG Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its 10x Genomics (TXG) stake by 62% in Q2 2026, buying an estimated $1.02M and bringing the position to 101,852 shares worth $3.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2288.

BNP Paribas Financial Markets first reported a position in TXG in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.08M in Q4 2024. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

BNP Paribas Financial Markets held 101,852 shares of 10x Genomics worth $3.91M as of Q2 2026.
BNP Paribas Financial Markets bought 38,980 10x Genomics shares in Q2 2026, an estimated $1.02M.
10x Genomics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2288 holding.
BNP Paribas Financial Markets first reported a position in 10x Genomics in Q4 2024 and has held it in 7 quarters since.
BNP Paribas Financial Markets's 10x Genomics position peaked at $9.08M in Q4 2024.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.